Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. - Wikidata - awgldk - TriplyDB

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q34525413

about

DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication The variable N-terminal region of DDX5 contains structural elements and auto-inhibits its interaction with NS5B of hepatitis C virus The pancreatic stellate cell: a star on the rise in pancreatic diseases A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus Gene expression and hepatitis C virus infection Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment.A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?Genome-wide association studies: progress and potential for drug discovery and development.Liver cirrhosis Age and ethnicity in cirrhosis.Predicting the probable outcome of treatment in HCV patients.Constitutional telomerase mutations are genetic risk factors for cirrhosis.No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C.Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality Role of host genetics in fibrosis.Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.Models and mechanisms of fibrosis resolution.Genetics of liver injury and fibrosis.Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection.Natural history of HCV infection.Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C.Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17)Non-biopsy methods to determine hepatic fibrosis.A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers.Noninvasive indices of fibrosis in NAFLD: starting to think about a three-hit (at least) phenomenon.The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection.Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants

P2860

Q24293603-7DE1489F-9A50-4047-BE76-1E63D53AB0DD Q24336907-8F0E4EC9-3B67-4435-BA63-69B2B8B11673 Q24676727-53A2D090-8A0D-4444-8A7E-A81DAE06C0B4 Q24680489-2009EB3B-5927-4826-8C06-CC0BD3FF5C0E Q27487445-7E648A50-10C6-424C-9CF3-9F2CA7A83121 Q27488345-3E25BF23-A647-4438-9BF8-B56E29ADD7C1 Q29417113-74243CF9-651A-486B-AFBD-F4BDAD971D8D Q30476922-6BB2F53F-4790-4F25-B6A5-1CAD290CEF4A Q33350754-8555CA34-03DA-48EE-9F70-93B77B599304 Q33648379-835D6751-7D52-44CC-8453-53A4A9211003 Q33731308-3DECAD6A-4AF9-4BCC-857F-22CEE2B8C98B Q33784699-CCF2612A-946A-4B17-AFE7-2C634E4A0662 Q34010340-B358D8E4-4AAB-493D-82F6-0A019E648D57 Q34231825-99A2ED93-B118-4611-A884-BB6D8A6891F2 Q34409039-05A3BEB3-9718-4C2C-BB6F-6BF02066588F Q34862975-34669A1D-026F-4950-9D53-9AC80542BBE6 Q35069533-50FDDE15-6EC4-4A04-9FF0-70902E578DF1 Q35547001-5983A4AE-9358-41F7-A8E1-1BBAB45E1164 Q35823055-E67009D4-624F-48B6-97F4-7620A8A720B4 Q35915073-ACD09A21-4BFA-4E67-8D9E-6BC8AE4BE911 Q35929511-581E3B2A-25BC-471A-854B-9FA46CFAFFEC Q35945962-028E075E-9ADF-406E-9FDF-7264F561B4D4 Q36990696-0295CF72-B580-40CC-94ED-10C96163591B Q37644559-C2AD5245-FA73-4539-AC61-F1EAB50721FC Q37654431-8077D3FC-5591-469D-B5F2-42A6E6C45623 Q37834043-C24CA723-6AE9-4EC6-B54D-922CA52A219C Q37834045-76F55001-BE3C-485E-A839-7769698BFB68 Q38088855-7CCB080C-3585-4866-BB67-51127C266827 Q38207382-697223F9-38FD-41DB-9858-71E4C89B4503 Q38299880-AB8AFA28-44C2-40A5-9C03-6FE782710D92 Q38552179-93B3530F-9825-4ACE-8084-F628F32612C6 Q40211269-2E907707-614B-426B-83CB-646336537412 Q41466680-5F514DD3-6BE6-4BBA-A164-837C96661FF9 Q42160967-FFF30E68-44EF-41F0-91F4-BF484B4028D8 Q42262070-0A9DA823-5BDD-459E-950A-99FE88021A84 Q43994762-5D15D5C0-8922-4ADF-84F8-F719C622259A Q44898803-B2A14F9D-D8C9-40E8-882A-3954F2E10CD4 Q45400167-98F563F9-3F13-4D27-8003-3E5CDB3068B0 Q53284479-5F700B8D-6ADF-497B-9A20-B71C5878F0D7 Q56769911-5827CBA4-9B80-4829-A28C-403DB4A3CB95

P2860

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

http://www.wikidata.org/entity/Q34525413

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Identification of two gene var ...... ents with chronic hepatitis C.

@ast

Identification of two gene var ...... ents with chronic hepatitis C.

@en

Identification of two gene var ...... ents with chronic hepatitis C.

@nl

type

label

Identification of two gene var ...... ents with chronic hepatitis C.

@ast

Identification of two gene var ...... ents with chronic hepatitis C.

@en

Identification of two gene var ...... ents with chronic hepatitis C.

@nl

prefLabel

Identification of two gene var ...... ents with chronic hepatitis C.

@ast

Identification of two gene var ...... ents with chronic hepatitis C.

@en

Identification of two gene var ...... ents with chronic hepatitis C.

@nl

P1433

Q34525413-B4A8009B-94BA-458C-A7A6-9DB9645B1205

P1476

Q34525413-9FC0220E-ECA0-4B37-AB3F-F37218702531

P2093

Q34525413-0E18B483-4672-417C-AFC1-2229BA611440

Q34525413-0F655B8F-1A7F-4907-AFFD-B29AE28D4BC0

Q34525413-13C00FD2-5333-4E94-90FC-0161BFD073AB

Q34525413-1610A6DC-9845-4D52-9BE5-23D74DDFEBBD

Q34525413-1F29D24A-7E70-44BC-9AF7-FD4091D269EF

Q34525413-49185037-65D7-46AE-B510-93360F8EA79F

Q34525413-49E156FA-ED0E-49D3-B85B-AC93A64BF9D3

Q34525413-689775E4-C508-4B80-8B4E-35EA61450EAE

Q34525413-6DC905DF-8E96-4136-8041-24F69382843D

Q34525413-74A01000-7D9F-4DBE-B7B5-521BBDCD0547

P304

Q34525413-BFB8DFBC-4774-481D-B7CE-EC670CFFA7C8

P31

Q34525413-D119A80C-B809-40EE-A6C1-5095BA47F9FA

P356

Q34525413-4A2A25E2-717B-461D-AD6A-8B3CC348E5D6

P407

Q34525413-F83580E6-46EA-4484-BEF0-26980002C23E

P433

Q34525413-F23460D3-0178-4AB7-8DDE-9EA24931E579

P478

Q34525413-FC94F192-7B56-46EF-9EC7-2FCDE880FD47

P50

Q34525413-04CF323D-5DCB-4AAB-AB77-09451251A9BA

P577

Q34525413-5BDBEC3A-B282-468B-8266-507372C9527F

P5875

Q34525413-BB90AC83-1CE2-46CD-AD82-4B21007C3AFF

P698

Q34525413-C27EFD71-49B6-43B0-8727-4EA9A8CAD0C5

P356

J.GASTRO.2006.02.032

P1433

Gastroenterology

P1476

Identification of two gene var ...... ients with chronic hepatitis C

@en

P2093

Alexander Monto

http://www.w3.org/2001/XMLSchema#string

Anand P Chokkalingam

http://www.w3.org/2001/XMLSchema#string

David Ross

http://www.w3.org/2001/XMLSchema#string

Diane U Leong

http://www.w3.org/2001/XMLSchema#string

Hongjin Huang

http://www.w3.org/2001/XMLSchema#string

Jason Chan

http://www.w3.org/2001/XMLSchema#string

John J Sninsky

http://www.w3.org/2001/XMLSchema#string

Joseph J Catanese

http://www.w3.org/2001/XMLSchema#string

Linda B McAllister

http://www.w3.org/2001/XMLSchema#string

Linda Yee

http://www.w3.org/2001/XMLSchema#string

P304

1679-1687

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2006.02.032

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Steven J. Schrodi

P577

2006-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7083159

http://www.w3.org/2001/XMLSchema#string

P698

16697732

http://www.w3.org/2001/XMLSchema#string